Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,303 total articles
Lauren Freemen-Bosworth, Pitney Bowes' Executive Vice President, General Counsel and Corporate Secretary, sold 169 shares of the company's common stock on April 21, 2026, for $2,408. The trade was carried out under a Rule 10b5-1 plan adopted October 31, 2025. Pitney Bowes recently reported fourth-quarter adjusted EPS above expectations but posted a…
Jorey Chernett, a roughly ten percent owner of Neuronetics, Inc. (NASDAQ: STIM), purchased 200,000 shares of the company's common stock across April 20-21, 2026, investing approximately $309,000. The transactions occurred as the stock posted a near 8% weekly gain but remained down about 49% over six months. The purchases follow the company’s fourth…
Home BancShares Chief Accounting Officer sold 3,000 shares on April 21, 2026, for $27.115 each, a transaction totaling $81,345. The sale leaves the officer with 4,635 directly held shares and 8,000 performance options. The move comes against a backdrop of mixed first-quarter results, analyst price-target reductions and the stock trading near its 52…
Fold Holdings Chief Financial Officer Repass Wolfe sold 236 shares of company stock on April 20, 2026, at $1.50 per share in a mandated sell-to-cover to meet tax withholding obligations tied to vested restricted stock units. The sale followed a conversion of 695 RSUs into common stock on April 17, 2026. Fold's shares have been under pressure over t…
Fold Holdings Chief Technology Officer Thomas J. Dickman sold 61 shares of company stock on April 20, 2026, at $1.50 per share to satisfy tax withholding obligations triggered by the vesting and settlement of restricted stock units. The shares were acquired through a one-for-one RSU conversion on April 17, 2026. The stock sale was non-discretionary…
Sheena Jonathan, a co-founder and director of Natera, Inc. (NTRA), sold 1,500 shares of common stock on April 17, 2026, for a total of $299,440 under Rule 10b5-1 trading arrangements. The sales were executed via two indirect holdings, the Caraluna 1 and Caraluna 2 trusts. The stock trades at $205.42 and the company carries a market capitalization o…
MeiraGTx Holdings plc executive Richard Giroux sold 56,000 ordinary shares on April 21, 2026, for proceeds of $572,320 under a previously adopted Rule 10b5-1 plan. The transaction follows a volatile week for the stock even as the company advances financing and gene therapy programs, including a $100 million share offering and the reacquisition of b…
Rui Zhang, vice president, chief accounting officer and corporate controller of Photronics Inc., sold 4,556 shares of company stock on April 17, 2026, realizing proceeds of $212,765. The transaction occurred even as Photronics reported fiscal Q1 2026 results that beat analyst forecasts and announced investments in photomask production capacity in K…
Helen Louise Collins, chief medical officer at Enliven Therapeutics, sold 4,900 shares of the company's common stock on April 17, 2026, generating roughly $238,352. The sale was executed under a Rule 10b5-1 plan that Collins adopted in October 2025. Prior to the sale she exercised 5,000 options at $2.48 per share. Following these moves she holds 25…
Peter A. Thompson, a director at Sionna Therapeutics, sold about $2.47 million of the company’s common stock across two trades in mid-April under a pre-established 10b5-1 plan. The transactions, executed at prices above the current market, leave the reporting entity with nearly 3.0 million shares. The company has received bullish analyst coverage a…
OrbiMed Advisors LLC and OrbiMed Capital GP VIII LLC sold a combined 55,345 shares of Sionna Therapeutics (NASDAQ:SION) on April 17-18, 2026, generating $2,472,342 in proceeds under a pre-arranged 10b5-1 trading plan. The transactions occurred at prices between $44.52 and $44.68 per share. Following the sales, the OrbiMed entities collectively reta…
Chris Wren, vice president of operations at Planet 13 Holdings Inc. (OTC Markets: PLNH), sold 32,500 shares between April 17 and April 20, 2026, for roughly $4,904. The company's stock trades near a 52-week low even as Q4 2025 showed sequential revenue growth and an improved gross margin. After prior acquisition activity and the recent disposals, W…
Nextelligence, Inc., an entity controlled by FreeCast, Inc. Chief Executive Officer William A. Mobley, Jr., sold 506,250 shares of FreeCast Class A common stock on April 17, 2026 for $3,300,000 and later converted a promissory note into additional shares. The same week the company renewed a revolving convertible promissory note and FreeCast disclos…
George Kurtz, president and chief executive officer of CrowdStrike Holdings, sold 4,400 shares of Class A common stock across transactions on April 17 and April 20, 2026, for approximately $2.13 million. The sales were made under a pre-established 10b5-1 plan adopted January 6, 2026, at prices between $418.32 and $433.15 per share. InvestingPro dat…
Third Rock Ventures executed a planned sale of roughly $17.1 million in common stock of Rapport Therapeutics (RAPP) on April 17, 2026. The disposal of 426,005 shares occurred under a Rule 10b5-1 trading program adopted November 21, 2025. The transactions coincide with strong clinical data for Rapport’s RAP-219 program and several analyst Buy reiter…
Astera Labs CEO Mohan Jitendra disposed of 335,861 shares across multiple transactions on April 17 and April 20, 2026, generating $57,852,785 in proceeds under a Rule 10b5-1 plan. The sales were processed through a living trust for which Jitendra is trustee. The company’s shares have climbed 253% over the past year and trade at $192.02; recent quar…
Scott Gates, a director at Aehr Test Systems, sold a total of $5,660,000 of common stock on April 21, 2026, per a Securities and Exchange Commission filing. The transactions involved multiple block sales at prices between $91.00 and $95.00 per share. The moves leave Mr. Gates with a direct holding of 52,864 shares, including shares subject to unves…
Kenneth Duda, Arista Networks' president and chief technology officer, sold roughly $9.47 million of common stock on April 17, 2026 under a Rule 10b5-1 trading plan. The sales coincided with the shares trading close to a 52-week high and followed recent analyst upgrades and raised AI revenue targets for the company.
RA Capital Healthcare Fund LP, managed by RA Capital Management, L.P., sold 630,374 shares of Vor Biopharma Inc. (NASDAQ: VOR) common stock in April 2026 for roughly $10,174,787. The sales took place on April 17 and April 20 at weighted average prices of $16.28 and $15.77 per share, respectively. After the transactions the fund retains 2,567,245 sh…
Mineralys Therapeutics Chief Medical Officer David Malcom Rodman exercised stock options and sold an equal number of shares under a prearranged trading plan on April 17, 2026. The transactions left Rodman with a direct holding of 69,792 shares. The insider activity comes as the stock has rallied over the past year and the company posts an earnings …
Llewellyn Lindsay Catherine, Lyft’s Chief Legal Officer and Corporate Secretary, executed a stock sale of 23,661 Class A shares on April 17, 2026 under a pre-established Rule 10b5-1 trading plan. The disposition totaled $354,915 and leaves her with 916,022 directly held shares. The move comes as Lyft’s shares trade below recent levels and amid comp…
MARA Holdings' CFO, Salman Hassan Khan, sold 16,000 shares under a pre-arranged Rule 10b5-1 plan on April 17, 2026, realizing $186,880. The company concurrently disclosed plans to repurchase roughly $1 billion of convertible senior notes at a discount, while Bitcoin’s rise supported gains in cryptocurrency-linked equities.
MARA Holdings Chief Executive Officer Frederick G. Thiel sold 27,505 shares of company stock on April 17, 2026 for $11.68 per share, netting $321,258. The transaction was carried out under a Rule 10b5-1 plan adopted May 28, 2025. The disclosure comes as MARA pursues repurchases of roughly $1 billion in convertible senior notes, funded via Bitcoin s…
Nowaid Zabi, general counsel of MARA Holdings, sold 42,090 shares on April 17, 2026 under a Rule 10b5-1 trading plan, generating roughly $505,080. The stock trades below the sale price and has been volatile. Separately, the company has arranged buybacks of approximately $1 billion in convertible senior notes, and recent strength in Bitcoin has supp…
Oasis Management Co Ltd. and affiliated entities sold 48,806 shares of Stratus Properties Inc. (NASDAQ: STRS) in transactions executed between April 17 and April 20, 2026, bringing the approximate proceeds to $1.46 million. The trades, executed at prices between $29.9043 and $30.0277 per share, follow a period in which the stock has risen 74% year-…
